Skip to main content

GOLDMAN SACHS GROUP INC

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 886982 NEW YORK, NY

Position in DNTH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$37,253,053
-$8,735,945 QoQ
Shares Held
382,161
-30.3% QoQ
Ownership
0.683%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 269 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in DNTH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. DNTH ranks #83 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNTH

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,253,053 382,161
2026-03-31 $45,988,998 548,010
2025-12-31 $23,778,952 577,019
2025-09-30 $8,608,637 218,771
2025-06-30 $6,792,348 364,592
2025-03-31 $1,332,019 73,430
2024-12-31 $4,535,860 208,067
2024-09-30 $2,206,991 80,606
2024-06-30 $1,083,569 41,869
2024-03-31 $5,106,510 170,217
2022-12-31 MGTA 38,059
2022-09-30 MGTA 111,761
2022-06-30 MGTA 122,387
2022-03-31 MGTA 162,079
2021-12-31 MGTA 187,020
2021-09-30 MGTA 171,871
2021-06-30 MGTA 153,225
2021-03-31 MGTA 61,584
2020-12-31 MGTA 77,558
2020-09-30 MGTA 94,236
2020-06-30 MGTA 76,989
2020-03-31 MGTA 42,874